Structural analogues of methylphenidate as parkinson's disease-modifying agents
AssigneesUniversita Degli Studi di Brescia, Universita' Degli Studi Di Milano
InventorsArianna BELLUCCI, Francesca LONGHENA, Ermanno VALOTI, Valentina STRANIERO, Andrea CASIRAGHI
Life of this patent
Estimating the term…
Abstract
The present invention describes compounds of formula (A) for use as Parkinson's disease modifying-agents, said formula (A). Surprisingly it has been found that the compounds of the invention can significantly reduce alpha-synuclein aggregation and stimulate the functional interaction between alpha-synuclein and Synapsin III.
Claims10
A disease-modifying method of treating Parkinson's disease comprising administering to a subject in need thereof an effective amount of a disease-modifying agent compound of formula (A), said formula (A)
- wherein
- R is H, Alk;
- R1 is H, Alk, OAlk, Ar;
- R2 is H, Alk, OAlk, Ar;
- R1 and R2 joined together can form an (hetero)aromatic ring;
- R3 is Me, Et, Pr and i-Pr;
- n=0,1;
- m=0,1;
- r=0,1;
- including pharmaceutical acceptable salt thereof,
- including threo and erythro racemates and (R,R) or (S,S) stereoisomers thereof,
- excluding methyl 2-phenyl-2-piperidin-2-ylacetate.
Dependencies are inferred from the claim text.